Q.V.SKIN Cutaneous Solution 5%w/w %w/w

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

WHITE SOFT PARAFFIN

Available from:

Ego Pharmaceuticals (UK) Limited

Dosage:

5%w/w %w/w

Pharmaceutical form:

Cutaneous Solution

Authorization date:

1998-01-09

Summary of Product characteristics

                                IRISH MEDICINES BOARD ACTS 1995 AND 2006
MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007
(S.I. NO.540 OF 2007)
PA0863/001/001
Case No: 2038246
The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to
EGO PHARMACEUTICALS (UK) LIMITED
15 WINDSOR PARK, 50 WINDSOR AVENUE, MERTON, LONDON SW19 2TJ, UNITED KINGDOM
an authorisation, subject to the provisions of the said Regulations, in respect of the product
Q.V.SKIN LOTION
The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as
may be specified in the said Regulations as listed on the reverse of this document.
This authorisation, unless previously revoked, shall continue in force from 07/08/2007 until 08/01/2008.
Signed on behalf of the Irish Medicines Board this
________________
A person authorised in that behalf by the said Board.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 22/09/2007_
_CRN 2038246_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Q.V. Skin Lotion
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Soft White Paraffin 5% w/w.
For excipients, see 6.1
3 PHARMACEUTICAL FORM
Cutaneous Solution.
White to off-white solution.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the symptomatic relief of dermatological conditions associated with dry skin including:
-
Ichthyosis
-
Pruritis hiemalis
-
Dry skin conditions associated with
-
Dermatitis
-
Eczema
-
Psoriasis
-
Exposure to sun, wind and cold weather.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Administration:
For cutaneous (topical) administration only.
Dosage:
The lotion should be appl
                                
                                Read the complete document